Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models.
Kristian Agmund HaanesAlejandro Labastida-RamírezFrank W BlixtEloisa Rubio-BeltránClemens M DirvenAlexander Hj DanserLars EdvinssonAntoinette MaassenVanDenBrinkPublished in: Cephalalgia : an international journal of headache (2019)
Both an agonist directed at the P2Y13 receptor and an antagonist of the P2X3 receptor seem to be viable potential anti-migraine therapies.